Trial

ACTG 5306 Phase I, Three-Arm Safety, Tolerability, and Pharmacokinetic Interaction Study of PA-824, an Investigational Nitroimidazole for the Treatment of Tuberculosis, Together With Efavirenz, Ritona

Study Director
Start Date
6 / 2012
Trial Phase
Trial Status
enrolling
Current Enrollment
4
Target Enrollment
48
Overview